Selected article for: "data set and SARS data set"

Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
  • Document date: 2020_4_14
  • ID: d7stppv5_54
    Snippet: The first data set was obtained from SARS Cov-2-infected patients followed at 4 hospital in Singapore from January 23 rd to February 23 rd , 2020 (7). All patients diagnosed stated to have travelled from Wuhan, China in the last two weeks of enrollment. Viral load observations were obtained from different specimens (blood, stool, and urine samples), but we analyzed those coming from nasopharyngeal swabs. Cycle threshold were obtained with reverse.....
    Document: The first data set was obtained from SARS Cov-2-infected patients followed at 4 hospital in Singapore from January 23 rd to February 23 rd , 2020 (7). All patients diagnosed stated to have travelled from Wuhan, China in the last two weeks of enrollment. Viral load observations were obtained from different specimens (blood, stool, and urine samples), but we analyzed those coming from nasopharyngeal swabs. Cycle threshold were obtained with reverse transcriptase polymerase chain reaction (RT-PCR) at multiple times during the first 2 weeks after enrollment.

    Search related documents:
    Co phrase search for related documents
    • data set and multiple time: 1, 2, 3, 4, 5, 6, 7, 8
    • data set and nasopharyngeal swab: 1, 2, 3, 4
    • data set and RT PCR transcriptase polymerase chain reaction: 1, 2
    • data set and SARS patient: 1, 2
    • data set and transcriptase polymerase: 1, 2
    • data set and transcriptase polymerase chain reaction: 1, 2
    • diagnose patient and nasopharyngeal swab: 1
    • diagnose patient and SARS patient: 1, 2, 3
    • different specimen and nasopharyngeal swab: 1, 2, 3
    • enrollment week and nasopharyngeal swab: 1
    • load observation and SARS patient: 1
    • load observation and viral load observation: 1, 2, 3
    • multiple time and nasopharyngeal swab: 1, 2, 3
    • multiple time and RT PCR transcriptase polymerase chain reaction: 1, 2, 3, 4
    • multiple time and SARS patient: 1, 2, 3
    • multiple time and transcriptase polymerase: 1, 2, 3, 4
    • multiple time and transcriptase polymerase chain reaction: 1, 2, 3, 4
    • nasopharyngeal swab and urine sample: 1, 2, 3
    • nasopharyngeal swab and urine sample stool: 1